A 2-treatment period, randomized, placebo-controlled, multicenter parallel-group study to assess the safety of QAW039 when added to existing asthma therapy in GINA steps 3, 4 and 5 patients with uncontrolled asthma

Authors
Category Primary study
Registry of TrialsOverview of Medical Research in the Netherlands
Year 2019
This article has no abstract
Epistemonikos ID: 49e23c846f090c17e91607df97e1833f30572426
First added on: Apr 11, 2025